Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
BridgeBio Pharma Inc
(BBIO)
NASDAQ
:BBIO
BBIO
BridgeBio Pharma
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
BridgeBio Pharma (BBIO) Stock News & Sentiment
Compare
Follow
1,438
Followers
Premium
Company Announcements
BridgeBio Showcases Attruby Growth and Pipeline Progress
6d ago
8K
BBIO
Premium
Ratings
BridgeBio Pharma: Emerging Rare Disease Leader With Robust Growth Outlook and Discounted Valuation Supporting Buy Rating
12d ago
BBIO
Premium
Ratings
BridgeBio Pharma: Buy Rating Backed by Promising Drug Pipeline and Strategic Market Positioning
1M ago
BBIO
Premium
Company Announcements
BridgeBio Pharma’s Earnings Call Highlights Success and Challenges
3M ago
BBIO
Premium
Company Announcements
BridgeBio Pharma Reports Strong Q3 2025 Results
3M ago
BBIO
Premium
Company Announcements
BridgeBio Pharma Reports Positive Phase 3 Study Results
3M ago
8K
BBIO
Premium
Ratings
Optimistic Buy Rating for BridgeBio Pharma: Promising Phase 3 Trial Results and Future Developments
3M ago
BBIO
More BBIO News >
BBIO News on the Web
All News
Bearish News
Bullish News
2026-01-16
Pre-Market Most Active for Jan 16, 2026 : IBRX, TQQQ, TSLL, BBIO, NVO, T, MU, RKLZ, QXO, NOK, SMR, RDW
NASDAQ.com
Neutral
2026-01-16
BridgeBio Pharma Prices $550 Mln Of 0.75% Convertible Senior Notes Due 2033
rttnews
Neutral
2026-01-08
Jefferies Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)
TipRanks News
Neutral
2026-01-06
Here are Tuesday's biggest analyst calls: Nvidia, Apple, Tesla, Palantir, Shake Shack, Brinker, Wells Fargo & more
CNBC
Neutral
2026-01-05
Bank of America Securities Remains a Buy on BridgeBio Pharma (BBIO)
TipRanks News
Neutral
2026-01-05
Why BridgeBio Pharma, Inc.’s (BBIO) Stock Is Down 5.61%
AAII
Neutral
2026-01-02
BridgeBio’s Upcoming Achondroplasia Webinar Set to Highlight Advancements in Skeletal Dysplasia Research
Market Chameleon
Neutral
2025-12-11
Here are Thursday's biggest analyst calls: Nvidia, Tesla, Oracle, Meta Platforms, Visa, Alphabet, Roku & more
CNBC
Neutral
132
Results | Showing
1
out of
17
News Score - Last 7 Days
Neutral
BBIO
Sector Average
Media Buzz
This Week
2 articles
Weekly Average
1.75 articles
News Sentiment
This Week
50%
Sector Average
57%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is BBIO’s Media Buzz Sentiment?
2 articles about BBIO were published this week. In an average week, 1.75 articles are published.
What is BBIO’s weekly average amount of articles?
In an average week, 1.75 articles about BBIO are published.
What is BBIO’s News Sentiment?
50% of articles about BBIO were positive this week, compared to its sector average of 57%.
Healthcare Stocks that are Trending in the News
CAH
Cardinal Health
ALKS
Alkermes
WST
West Pharmaceutical Services
AGEN
Agenus
PEN
Penumbra
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.